Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation
Clinical trial NCT03693339 · UNKNOWN
Trial details
- NCT number
- NCT03693339
- Sponsor
- Asan Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-30
- Primary completion
- 2020-06-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.